• Company
  • Overview
  • Management
  • Board of Directors
  • Investors
• Product Programs
  • Overview
  • Cardio-Renal
  • Pre-eclampsia
  • Sepsis
  • Ovarian Cancer
• Technology
  • Overview
  • MASStermind^®
  • MASSterclass™
  • Publications
• Business Development
  • Partnerships
  • Collaborations
• News
  • Press Releases
  • Conferences & Events
• Jobs
• Contact
  • General
  • Directions

Pronota is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including pre-eclampsia, ovarian cancer and sepsis. Our non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare.